Vesicare and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Vesicare (solifenacin succinate), especially for people who are female, 50-59 old, also take Advair Hfa, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Otitis when taking Vesicare. It is created by eHealthMe based on reports of 29,875 people who have side effects when taking Vesicare from the FDA, and is updated regularly.

What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,656 Vesicare users. Check the latest studies of Vesicare.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,422 drugs and 1,831 conditions by eHealthMe. Check the latest studies of Otitis.

On Jul, 10, 2026

29,875 people reported to have side effects when taking Vesicare.
Among them, 46 people (0.15%) have Otitis.

Among these 46 people:

What is the gender of people who have Otitis when taking Vesicare? *

female: 84.78 %
male: 15.22 %

What is the age of people who have Otitis when taking Vesicare? *

What are other drugs people take besides Vesicare? *

What are other side effects people have besides Otitis? *

Sinusitis (inflammation of sinus): 20 people, 43.48%
Urinary Tract Infection: 19 people, 41.30%
Cough: 14 people, 30.43%
Fatigue (feeling of tiredness): 13 people, 28.26%
Headache (pain in head): 13 people, 28.26%
Nausea (feeling of having an urge to vomit): 13 people, 28.26%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 12 people, 26.09%
Nasopharyngitis (inflammation of the nasopharynx): 11 people, 23.91%
Pain: 11 people, 23.91%
Itching: 10 people, 21.74%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 11 people, 23.91%
Primary Immunodeficiency Syndrome: 6 people, 13.04%
Stress And Anxiety: 6 people, 13.04%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 8.70%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 6.52%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 6.52%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 6.52%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 6.52%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 6.52%
Parkinson's Disease: 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Vesicare and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vesicare:

Vesicare (30,656 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Vesicare:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,422 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,831 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on solifenacin succinate (the active ingredients of Vesicare) and Vesicare (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.